Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
EFCAB3 pseudogene 1 (EFCAB3P1) is classified as a pseudogene in humans. Pseudogenes are genomic DNA sequences similar to normal genes but are nonfunctional; they typically arise from gene duplication or retrotransposition events and generally do not encode functional proteins. EFCAB3P1 does not have any well-characterized molecular function, biological process involvement, or association with any disease. It does not serve as a therapeutic or drug target. EFCAB3P1 is a pseudogene and does not encode a functional protein; it is not a receptor, enzyme, or other classical therapeutic target. It has no known biological or pathological function and no known interactions with drugs or biomarker use. Its only commonly reported alias is HILPDA-AS1. No information suggests incorrect naming or confusion, but it is sometimes mistaken for the protein-coding gene EFCAB3 (EF-hand calcium binding domain 3), which is a distinct entity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on EFCAB3 pseudogene 1 (EFCAB3P1).